Technology Search
Your search returned '20' results
-
NeuroAD for mild and moderate Alzheimer’s Disease
Agency: NIHR-HSC
Name: NeuroAD
Technology Type: Device
Patient Indications: Patients with mild and moderate Alzheimer’s disease
Entered On: May 21 2013
-
Cardiovascular Magnetic Resonance (CMR) for the diagnosis of coronary heart disease
Agency: HPACT
Name: multiple devices (see Table 1 in the report on the weblink)
Technology Type: Procedure
Patient Indications: Patients with coronary heart disease (CHD).
Entered On: May 20 2013
-
Margin Probe® to assess surgical margins during lumpectomy for breast cancer
Agency: HPACT
Name: MarginProbe®
Technology Type: Device
Patient Indications: Patients with breast cancer undergoing lumpectomy during breast conservation surgery
Entered On: May 20 2013
-
Antibiotics versus appendectomy for uncomplicated appendicitis
Agency: HPACT
Name: Antibiotics
Technology Type: Drug
Patient Indications: Patients with uncomplicated appendicitis
Entered On: May 20 2013
-
autoRIC™ Device for Remote Ischaemic Conditioning
Agency: NIHR-HSC
Name: autoRIC™ Device
Technology Type: Device
Patient Indications: The autoRIC™ Device is intended for use in adults with the following indications: • Cardiothoracic surgery (e.g. coronary artery bypass grafting) • Interventional cardiothoracic procedures (e.g. percutaneous coronary interventions) • Patients with suspected (evolving) myocardial infarction
Entered On: May 20 2013
-
Glysure intravascular continuous glucose monitoring system for glycaemic control in intensive care
Agency: NIHR-HSC
Name: Glysure intravascular continuous glucose monitoring system
Technology Type: Diagnostics Device
Patient Indications: The Glysure intravascular continuous glucose monitoring system is designed for glycaemic control in patients who are in intensive care.
Entered On: May 10 2013
-
Optical biopsy probe to diagnose bladder cancer
Agency: Agenas (COTE)
Name: UroFlex
Technology Type: Diagnostics
Patient Indications: Suspected bladder cancer.
Entered On: May 9 2013
-
High-energy acoustic pressure waves in wound healing
Agency: Agenas (COTE)
Name: dermaPACE
Technology Type: Device
Patient Indications: Treatment of acute and chronic defects of the skin and subcutaneous soft tissues e.g. post-operative wound healing defects, post-traumatic wounds, deep partial thickness burns, decubitus ulcers, diabetic ulcers, and arterial ulcers.
Entered On: May 9 2013
-
Anti-inflammatory treatment for Crohn's disease - NNC142-0002
Agency: ICET
Name: Anti-inflammatory treatment for Crohn's disease - NNC142-0002
Technology Type: Drug
Patient Indications: Active Crohn's disease
Entered On: May 9 2013
-
Rotational thromboelastometry – targeted therapy for coagulation management in massive bleeding
Agency: HPACT
Name: ROTEM® delta
Technology Type: Device
Patient Indications: Patients undergoing major surgeries who are at high risk of bleeding.
Entered On: April 30 2013
-
Ophthalmic high intensity focussed ultrasound for glaucoma
Agency: HPACT
Name: EyeOP1
Technology Type: Device
Patient Indications: Patients with glaucoma
Entered On: May 6 2013
-
Biodegradable polymer drug-eluting stents
Agency: HPACT
Name: Nobori®, BioMatrix Flex®, Orsiro, TIVOLI®, ISAR®
Technology Type: Device
Patient Indications: patients with coronary artery disease.
Entered On: May 6 2013
-
Monarch External Trigeminal Nerve Stimulation (eTNS) System for depression
Agency: NIHR-HSC
Name: Monarch eTNS System
Technology Type: Device
Patient Indications: Patients aged nine years and over with depression.
Entered On: May 1 2013
-
Monarch External Trigeminal Nerve Stimulation (eTNS) System for epilepsy
Agency: NIHR-HSC
Name: Monarch eTNS System
Technology Type: Device
Patient Indications: Drug-resistant epilepsy (in patients aged nine years and above), to reduce the number of epileptic seizures.
Entered On: May 1 2013
-
Robotic video-assisted lung resection
Agency: HPACT
Name: da Vinci Surgical System
Technology Type: Procedure Device
Patient Indications: Patients with resectable lung tumours, particularly non-small cell lung cancer (NSCLC)
Entered On: April 30 2013
-
Gelatin foam impregnated with basic fibroblast growth factor (b-FGF) solution
Agency: HPACT
Name: Spongel, Plenac, Fibrast,, Bolheal
Technology Type: Procedure Drug Device
Patient Indications: Patients with tympanic membrane perforation due to trauma or severe otitis media.
Entered On: April 30 2013
-
Autologous blood injection for soft tissue injury
Agency: HPACT
Name: Autologous blood injection
Technology Type: Procedure
Patient Indications: Patients with soft tissue injuries
Entered On: April 30 2013
-
Pulse oximetry for detecting heart defects in newborns
Agency: HPACT
Name: Pulse oximetry
Technology Type: Device
Patient Indications: Newborns with critical congenital heart defects
Entered On: April 30 2013
-
The CoreValve® TAVI device for the treatment of symptomatic aortic valve stenosis
Agency: HPACT
Name: CoreValve®
Technology Type: Device
Patient Indications: Patients with severe aortic stenosis who are contraindicated for traditional surgical aortic valve replacement
Entered On: April 30 2013
-
External aortic root support in Marfan syndrome
Agency: HPACT
Name: ExoVasc®
Technology Type: Device
Patient Indications: Patients with Marfan syndrome
Entered On: April 30 2013